1. Home
  2. RYTM vs BKU Comparison

RYTM vs BKU Comparison

Compare RYTM & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • BKU
  • Stock Information
  • Founded
  • RYTM 2008
  • BKU 2009
  • Country
  • RYTM United States
  • BKU United States
  • Employees
  • RYTM N/A
  • BKU N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • BKU Savings Institutions
  • Sector
  • RYTM Health Care
  • BKU Finance
  • Exchange
  • RYTM Nasdaq
  • BKU Nasdaq
  • Market Cap
  • RYTM 3.1B
  • BKU 2.8B
  • IPO Year
  • RYTM 2017
  • BKU 2011
  • Fundamental
  • Price
  • RYTM $57.07
  • BKU $39.63
  • Analyst Decision
  • RYTM Strong Buy
  • BKU Hold
  • Analyst Count
  • RYTM 10
  • BKU 10
  • Target Price
  • RYTM $66.90
  • BKU $41.30
  • AVG Volume (30 Days)
  • RYTM 549.1K
  • BKU 719.6K
  • Earning Date
  • RYTM 02-20-2025
  • BKU 01-22-2025
  • Dividend Yield
  • RYTM N/A
  • BKU 2.90%
  • EPS Growth
  • RYTM N/A
  • BKU N/A
  • EPS
  • RYTM N/A
  • BKU 2.44
  • Revenue
  • RYTM $112,530,000.00
  • BKU $919,935,000.00
  • Revenue This Year
  • RYTM $63.77
  • BKU N/A
  • Revenue Next Year
  • RYTM $44.91
  • BKU $7.23
  • P/E Ratio
  • RYTM N/A
  • BKU $16.38
  • Revenue Growth
  • RYTM 81.55
  • BKU 3.57
  • 52 Week Low
  • RYTM $35.17
  • BKU $24.34
  • 52 Week High
  • RYTM $68.58
  • BKU $44.45
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 52.43
  • BKU 57.21
  • Support Level
  • RYTM $52.71
  • BKU $39.04
  • Resistance Level
  • RYTM $60.12
  • BKU $40.85
  • Average True Range (ATR)
  • RYTM 2.11
  • BKU 1.08
  • MACD
  • RYTM -0.00
  • BKU 0.28
  • Stochastic Oscillator
  • RYTM 58.93
  • BKU 80.79

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

Share on Social Networks: